Research group on metabolic syndrome : Metabolic syndrome and health outcome in Korea
Thursday 28 September 15:00~17:00 | Place: Convention Hall A
Chairman: Hak Chul Jang
    • Metabolic syndrome independently predicts future diabetes in women with a history of gestational diabetes This symposium is consisted of four hot-topics relating to the clinical consequence of metabolic syndrome. Professor EY Lee will review and summarize the relationship and the mechanism between metabolic syndrome and the prevalence of specific cancers based on the published studies. Professor HJ Chin is a nephrologist. Patients with chronic kidney disease and with metabolic syndrome are sharing many risk factors, especially associated with cardiovascular disease. He will present the common linking and consideration between CKD and metabolic syndrome. Professor DJ Kim had many studies of cardiometabolic risk scores and its outcomes. He will present the interesting Korean data for this topic. The last speaker will be Professor CH Ahn, he recently published the data that the components of metabolic syndrome in patients with gestational diabetes will predict the future diabetes.
Eun Young Lee The Catholic University of Korea, Korea RG1-1 Metabolic syndrome and incidence of cancer in nationwide study
Ho Jun Chin Seoul National University, Korea RG1-2 Metabolic syndrome and chronic kidney disease
Dae Jung Kim Ajou University, Korea RG1-3 Risk factors for cardiovascular events and mortality in diabetes
Chang Ho Ahn Seoul National University, Korea RG1-4 Metabolic syndrome and future diabetes in women with a history of gestational diabetes
Research group on diabetic vascular cell biology : Vascular and regenerative medicine
Thursday 28 September 15:00~17:00 | Place: Convention Hall B
Chairman: Joong Yeol Park
    • Attempt to protect and regenerate diabetes-associated vascular disease Vascular diseases are major causes of diabetic complications. A better understanding of the mechanisms leading to vascular dysfunction may unmask new strategies to reduce cardiovascular morbidity and mortality in patients with diabetes. Over the last years our knowledge on the mechanisms involved in the pathogenesis of diabetes related vascular disease has been enriched by the discovery of new molecules emerging as novel risk factors. Professor Bae will talk about link between vascular cells during angiogenesis and Professor Kim will talk dysregulation of RANKL/RANK system as a cause for cardiovascular disease. There were many advances in therapy, but they were focused on the modification of risk factors. Here we will discuss more new treatment modalities. Current vascular and endovascular management will be presented by Professor Park. Professor Choi will talk about stem cell based management in diabetic vasculopathy.
Sun Sik Bae Pusan National University, Korea RG2-1 Vascular crosstalk during retinal angiogenesis
Jaetaek Kim Chungang University, Korea RG2-2 he role of RANKL in retinal angiogenesis
Yang-Jin Park Sungkyunkwan University, Korea RG2-3 Current vascular and endovascular management of diabetic vasculopathy
Dong Hoon Choi Yonsei University, Korea RG2-4 Stem cell based management in diabetic vasculopathy
Research group on diabetic neuropathy : State-of-the-art in diabetic neuropathy
Thursday 28 September 15:00~17:00 | Place: Convention Hall C
Chairman: Tae Sun Park
    • Research group on diabetic neuropathy Diabetic neuropathy (DN) is the most common complication of diabetes mellitus (DM) and t hree broad types of neuropathy: sensory, autonomic and motor. Many clinical trials of treatments for DN in which participants were stratified by pain phenotype or comorbidities in the analysis of therapy efficacy. Major clinical manifestations of diabetic autonomic neuropathy were vary and associated with various organs and increased mortality. Recent preclinical studies on the use of gene or cell therapy have provided promising results in the treatment of DN. For making an understanding of managing DN, we will discuss about the management of diabetic peripheral neuropathy, diabetic autonomic neuropathy and new update data of stem cell therapy for DN. First speaker, prof Jong Chul Won will present about a critical reconsideration of the treatment of diabetic neuropathy based on clinical phenotype. The next speaker, prof Eun Yeong Mo discuss about the practical tips in diagnosis and treatment of autonomic neuropathies in diabetes. Last speaker, prof SungWan Chun will give a lecture induced pluripotent stem cells (iPSCs) for therapy of diabetic peripheral neuropathy. Three panelists, Seong Su Moon, Ie Byung Park, and Chong Hwa Kim, will discuss about the three topics of DN.
Jong Chul Won Inje University, Korea RG3-1 A critical reconsideration of the treatment of diabetic neuropathy based on clinical phenotype
Sang Soo Kim Pusan National University, Korea RG3-2 Practical tips in diagnosis and treatment of autonomic neuropathies in diabetes
Sung Wan Chun Soonchunhyang University, Korea RG3-3 Induced pluripotent stem cells (iPSCs) for therapy of diabetic peripheral neuropathy
Seong Su Moon Dongguk University, Korea RG3-P1 Panel discussion
Ie Byung Park Gachon University, Korea RG3-P2 Panel discussion
Chong Hwa Kim Sejong general hospital, Korea RG3-P3 Panel discussion
Quick Menu
Registration
Abstract
On-line submission
Venue
venue
Top